Evaluation of the effectiveness and tolerance of tetracosactide in the treatment of post-dural puncture headaches (ESYBRECHE): a study protocol for a randomised controlled trial

DiscussionWe expect a decrease in the use of epidural blood patch in those receiving tetracosactide, thus indicating a decrease in PDPH symptoms in these patients. This will define the therapeutic success of tetracosactide and the possibility to use this treatment as a non-invasive alternative to blood patch for PDPH treatment.Trial registrationPrimary RegistryClinicalTrials.gov Protocol Registration and Results SystemDate of Registration 24 June 2016Unique Protocol ID 69HCL15_0429Secondary IDsEudraCT Number 2015 –003357-17ClinicalTrials.gov IDNCT02813655ANSM 160214A-31Protocol versionV4 28/09/2018
Source: Trials - Category: Research Source Type: clinical trials